当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:73.43亿  总市值:78.49亿
流通股本:20.86亿   总股本:22.30亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.97亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益240563.70万元,未分配利润-20960.95万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产314159.56万元,负债73595.86万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入539,105,711.332,135,451,494.881,664,997,338.491,099,501,266.79
营业总成本463,882,978.061,906,201,168.541,463,760,914.56977,868,310.54
其他经营收益
营业利润107,268,905.61404,911,016.92265,253,964.82151,873,392.57
利润总额107,129,960.84409,616,937.61269,333,326152,089,011.49
净利润96,667,211.33382,357,127.75247,923,573.93137,424,012.98
每股收益
其他综合收益-1,530,963.76-1,098,908.06-639,692.29-159,250.63
综合收益总额95,136,247.57381,258,219.69247,283,881.64137,264,762.35
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,349,111,397.171,318,845,985.971,149,038,353.7988,789,329.67
非流动资产:
非流动资产合计1,792,484,158.631,815,731,813.981,880,921,737.961,910,814,912.15
资产总计3,141,595,555.83,134,577,799.953,029,960,091.662,899,604,241.82
流动负债:
流动负债合计709,563,333.96797,849,403.68825,780,524.56803,842,424.56
非流动负债:
非流动负债合计26,395,220.2327,154,017.7826,399,808.8528,287,214.94
负债合计735,958,554.19825,003,421.46852,180,333.41832,129,639.5
所有者权益(或股东权益):
归属于母公司股东权益合计2,387,993,475.442,293,671,990.182,157,141,926.532,047,939,272.39
股东权益合计2,405,637,001.612,309,574,378.492,177,779,758.252,067,474,602.32
负债和股东权益合计3,141,595,555.83,134,577,799.953,029,960,091.662,899,604,241.82
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计584,768,616.122,479,951,968.011,936,541,711.791,261,295,248.11
经营活动现金流出小计512,058,326.842,206,596,454.541,628,276,851.381,106,080,469.58
经营活动产生的现金流量净额72,710,289.28273,355,513.47308,264,860.41155,214,778.53
投资活动产生的现金流量:
投资活动现金流入小计447,631,423.671,321,760,890.23979,014,562.57708,336,463.16
投资活动现金流出小计179,282,920.311,654,113,698.981,307,839,226.981,023,318,605.54
投资活动产生的现金流量净额268,348,503.36-332,352,808.75-328,824,664.41-314,982,142.38
筹资活动产生的现金流量:
筹资活动现金流入小计-90,000,00070,000,00070,000,000
筹资活动现金流出小计73,543,343.06114,050,434.3890,260,190.1588,725,853.26
筹资活动产生的现金流量净额-73,543,343.06-24,050,434.38-20,260,190.15-18,725,853.26
汇率变动对现金及现金等价物的影响-1,436,780.01-1,887,808.59-968,043.41-266,848.95
现金及现金等价物净增加额266,078,669.57-84,935,538.25-41,788,037.56-178,760,066.06
期末现金及现金等价物余额661,907,577.33395,837,152.2438,984,652.89302,012,624.39
补充资料:
现金及现金等价物的净增加额--84,935,538.25--178,760,066.06
最新报告期:2026-02-25
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
江海证券吴春红0.160.130.162026-02-25
TOP↑